Understanding and Operationalizing A Complex Adaptive Design

   

A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology for running a phase II adaptive design trial with the goal of expediting a go/no-go decision for a specific patient population.  The sponsor's challenge was that they didn't fully understand the complex methodology enough to explain it nor design the actual trial.  

Read the case study to learn how and why Veristat was able to implement the design and help the sponsor reach thier go/no-go decision quickly.